CJC-1295 + Ipamorelin 10mg

Description

CJC-1295 + Ipamorelin 10mg is listed by Purity Collective as a lyophilized research blend for qualified laboratory procurement. This page is written to help a purchaser confirm the catalog identity, listed quantity, current batch documents and research-use boundary before ordering.

CJC-1295 + Ipamorelin 10mg catalog facts

• Product: CJC-1295 + Ipamorelin 10mg
• Format: Lyophilized vial
• Listed quantity: 10mg total blend, represented by the current documents as 5mg Ipamorelin and 5mg CJC-1295 no DAC
• SKU: PC-CJC-1295-IPAMORELIN-10MG
• Current certificate batch: PCCL-3437208-P

Available documentation

The current product attachments include a component UPLC/MS report and an endotoxin report. Review both files together because component identity and endotoxin information are split across separate PDFs.

• UPLC/MS component report for batch PCCL-3437208-P
• Endotoxin report for related batch PCCL-3437208-E
• How to read a peptide COA
• CJC-1295 + Ipamorelin research and COA guide

Component-specific report details

The UPLC/MS report lists a 5mg specification for each component. It reports Ipamorelin at 4.9mg with 99.28% purity and CJC-1295 no DAC at 4.9mg with 99.36% purity. These are component-specific results for the tested sample; they should not be rewritten as one blanket blend-wide purity claim.

Endotoxin report details

The endotoxin PDF lists related batch PCCL-3437208-E and reports <0.05 EU/mL. Both the UPLC/MS and endotoxin reports show analysis conducted on May 4, 2026 and a received date of May 9, 2026, so the chronology should be read exactly as printed. The endotoxin report does not print a separate acceptance specification.

Documentation scope

The current documents support a cautious component-by-component review of the listed research blend. They do not convert the product into a treatment, wellness, performance, consumer-use or human-use product, and they should not be used to imply clinical suitability.

CJC-1295 + Ipamorelin 10mg FAQs

What is listed on this page?

This page lists a CJC-1295 + Ipamorelin 10mg lyophilized research blend from Purity Collective, with SKU PC-CJC-1295-IPAMORELIN-10MG and current documents tied to batch PCCL-3437208-P.

What does the 10mg quantity mean?

The current documentation represents the blend as 5mg Ipamorelin and 5mg CJC-1295 no DAC. The product attribute should be read as 10mg total, not 10mg of each component.

Which analytical documents are available?

The listing includes a UPLC/MS component report and a separate endotoxin report. The UPLC/MS report gives component-specific quantity and purity results; the endotoxin report gives the <0.05 EU/mL result for the related endotoxin batch.

Does 99.36% describe the entire blend?

No. The 99.36% value belongs to the CJC-1295 no DAC component in the UPLC/MS report. The same report lists Ipamorelin separately at 99.28%, so public copy should keep those values component-specific.

Is CJC-1295 + Ipamorelin 10mg intended for human use?

No. This listing is for qualified laboratory research use only. It is not offered for human or veterinary use, and no protocol, administration or outcome guidance is provided.

Research-use notice

Review the product label, batch documentation and institutional requirements before procurement. If a required certificate, specification or document field is not visible, treat that information as unverified until the current product documentation is supplied.